Sertraline safety and efficacy in major depression: A double-blind fixed-dose comparison with placebo
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 38 (9) , 592-602
- https://doi.org/10.1016/0006-3223(95)00178-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Gas chromatographic—mass spectrometric analysis and preliminary human pharmacokinetics of sertraline, a new antidepressant drugJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of β-adrenoceptor system of rat brainEuropean Journal of Pharmacology, 1987
- Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depressionEuropean Journal of Pharmacology, 1987
- Double-blind dose determination study of a new antidepressant?sertralineDrug Development Research, 1986
- Effects of Antidepressant Medication on SexualJournal of Clinical Psychopharmacology, 1986
- Use of Specific Serotonin Uptake Inhibitors as AntidepressantsClinical Neuropharmacology, 1985
- Biogenic amine hypothesis of affective disordersLife Sciences, 1979
- QUANTITATIVE RATING OF DEPRESSIVE STATESActa Psychiatrica Scandinavica, 1975
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960